NCT02202538

Brief Summary

This study will evaluate the Indego® device for safety and effectiveness at allowing persons with SCI who are non-ambulatory or poorly ambulatory to stand up and walk under a variety of conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2014

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 29, 2014

Completed
3 days until next milestone

Study Start

First participant enrolled

August 1, 2014

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

December 20, 2016

Completed
Last Updated

July 25, 2017

Status Verified

June 1, 2017

Enrollment Period

1.2 years

First QC Date

July 23, 2014

Results QC Date

October 26, 2016

Last Update Submit

June 26, 2017

Conditions

Keywords

SCIIndegoWalking

Outcome Measures

Primary Outcomes (5)

  • Percentage of Subjects Able to Complete the 600 Meter Walk Test (600MWT)

    Measured time for an individual to complete walking 600 meters on a level surface with the Indego and stability aid at the end of the study, proposed to be representative of an individual's ability to ambulate in the community.

    8 weeks

  • Average Speed of 10 Meter Walk Test (10MWT) Mid Study Versus End of Study

    Measured time for an individual to complete walking 10 meters with the Indego and a stability aid midway through the study and at the end of the study.

    4 weeks, 8 weeks

  • Timed Up and Go (TUG) Test

    Measures the time required for an individual to stand from a seated position, walk three meters, turn, walk back three meters, turn and return to a seated position.

    8 weeks

  • Average Time to Don/Doff Device

    Time needed for an individual to don or doff the device.

    8 weeks

  • Percentage of Subjects That Could Don/Doff the Device Independently

    The percentage of participants that could don/doff the device independently at the end of the study, without the help of their Physical Therapist.

    8 weeks

Secondary Outcomes (3)

  • Walking Index for Spinal Cord Injury (WISCI-II) Assessment

    8 weeks

  • Functional Independence Measure (FIM) Score for Walking Indoors

    8 weeks

  • Borg Rating of Perceived Exertion (BRPE) for Walking Indoors

    8 weeks

Study Arms (1)

Indego

EXPERIMENTAL

Indego

Device: Indego

Interventions

IndegoDEVICE

Indego

Indego

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be 18 years or older
  • Height 5'1" to 6'3" (Acceptable height may vary by a few inches depending on femur length).
  • Hip width as measured in sitting no greater than 16.6" (42 cm) (acceptable hip width may vary depending on soft tissue).
  • Femur length as measured in sitting must be between 14 inches (35.5cm) and 18.5 inches (47 cm)
  • Weight 250lbs (113.4 kg) or less
  • Present with Spinal Cord Injury and NLI C5 and lower, with ISNCSCI A, B, C or D who are non-ambulatory or poorly ambulatory.
  • There are no restrictions on time since injury. However, each subject must have signed medical clearance/approval for full weight bearing and locomotor training.
  • Determined to have sufficient bone health for walking with full weight bearing without undue risk for fracture. Meeting of this criterion is at the discretion of each subject's personal MD and must be approved by each site's Medical PI.
  • Passive range of motion (PROM) at shoulders, trunk, upper extremities and lower extremities within functional limits for safe gait and use of appropriate assistive device/stability aid.
  • Skin must be intact where it interfaces with robotic device
  • Modified Ashworth Scale for spasticity score must be 3 or less.
  • Blood pressure and heart rate within established guidelines for locomotor training:
  • At rest; Systolic 150 or less Diastolic 90 or less and Heart rate 105 or less
  • Exercise; Systolic 180 or less Diastolic 105 or less and Heart Rate 145 or less
  • Tolerate being in an upright standing position (passive or active) without being lightheaded or having a headache.

You may not qualify if:

  • Weight in excess of 250 lbs
  • Heterotopic ossification that, in the opinion of the investigator, would place the subject at undue risk for fracture.
  • Any subject deemed at increased risk for injury by Medical Personnel
  • Lower extremity joint limitation that exceeds 10 degrees at their hips, knees or ankles.
  • Light headedness or headache in standing position (active or passive)
  • Moderate to Severe Traumatic (or Acquired) Brain Injury
  • Inability to follow instructions
  • Colostomy bag
  • Women who are pregnant or attempting to become pregnant during the study intervention.
  • Unable to obtain informed consent (either from the subject or from the subjects Legally Authorized Representative).
  • Any disease, concomitant injury, or condition that interferes with the performance or interpretation of the protocol specified assessments
  • Unlikely to be available for follow-up phone call.
  • Any other issue which, in the opinion of the investigators, will make the subject unsuitable for study participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Craig Hospital

Englewood, Colorado, 80113, United States

Location

Shepherd Center

Atlanta, Georgia, 30309, United States

Location

Rehabilitation Institue of Chicago

Chicago, Illinois, 60611, United States

Location

Kessler Institute for Rehabilitation

West Orange, New Jersey, 07052, United States

Location

RUSK Rehabilitation Center

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Results Point of Contact

Title
Ryan Farris
Organization
Parker Hannifin Corporation

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2014

First Posted

July 29, 2014

Study Start

August 1, 2014

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

July 25, 2017

Results First Posted

December 20, 2016

Record last verified: 2017-06

Locations